BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Trimeris Inc.

About TRIMERIS Inc.

Trimeris (Nasdaq: TRMS) is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of viral diseases. Their core technology platform focuses on compounds that inhibit viral replication by blocking viral fusion with healthy immune cells.

FUZEON®, approved by the US FDA and European Commission in 2003, is the first in a new class of anti-HIV drugs called fusion inhibitors.

 

PRODUCT INFORMATION

 

FUZEON (T-20)

T-1249

 

More About Trimeris

Home Page

Key Statistics for Trimeris

Basic Chart for Trimeris

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com